Paul B. Bolno's most recent trade in Wave Life Sciences Ltd. was a trade of 1,000,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 1,000,000 | 1,000,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 165,000 | 286,000 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.45 per share. | 05 Feb 2026 | 10,480 | 275,520 (0%) | 0% | 13.5 | 140,956 | Ordinary Shares |
| Invivyd Inc | Paul B. Bolno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 22 Aug 2025 | 217,351 | 121,000 (0%) | 0% | 10.1 | 2,194,810 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Mar 2025 | 169,025 | 507,376 (1%) | 0% | 2.5 | 419,182 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 07 Mar 2025 | 169,025 | 338,351 (0%) | 0% | 9.6 | 1,617,569 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 120,966 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 48,059 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 1,000,000 | 1,000,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 121,000 | 338,351 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Bolno B. Paul | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 50,000 | 47,778 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | B. Paul Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 25 Nov 2024 | 50,000 | 217,351 (0%) | 0% | 15 | 750,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Bolno Paul B. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 25 Nov 2024 | 50,000 | 267,351 (0%) | 0% | 2.5 | 124,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.32 per share. | 15 Nov 2024 | 51,234 | 217,351 (0%) | 0% | 14.3 | 733,671 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Oct 2024 | 90,474 | 268,585 (0%) | 0% | 15 | 1,357,110 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 21 Aug 2024 | 48,366 | 359,059 (1%) | 0% | 5.8 | 279,555 | Ordinary Shares |
| Wave Life Sciences Ltd | Bolno B. Paul | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 1,008,600 | 1,008,600 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 771,000 | 771,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.04 per share. | 16 Feb 2023 | 29,400 | 407,425 (1%) | 0% | 4.0 | 118,776 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 180,000 | 180,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 92,500 | 470,326 (1%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 04 May 2022 | 33,501 | 436,825 (1%) | 0% | 1.7 | 57,622 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 16 Feb 2022 | 33,150 | 377,826 (1%) | 0% | 2.3 | 76,908 | Ordinary Shares |
| Wave Life Sciences Ltd | Paul B. Bolno | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 600,000 | 600,000 | - | - | Share Option (right to buy) |